Glissmann, head of asset allocation research at Goldman Sachs, on the outperformance of European and Chinese stocks over the ...
There's no question the financial services industry is home to some of the world's most dominant businesses. One such company ...
Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...
Investors might be surprised to learn that in the past five years, shares of Goldman Sachs (NYSE: GS) have soared 186%.
Couchbase (NASDAQ:BASE – Free Report) had its target price trimmed by The Goldman Sachs Group from $18.00 to $16.00 in a ...
The Goldman Sachs Group Issues Pessimistic Forecast for Relay Therapeutics (NASDAQ:RLAY) Stock Price
Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective lowered by The Goldman Sachs Group from $20.00 to ...
Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price objective hoisted by The Goldman Sachs Group from $13.00 to ...
Goldman Sachs thinks these mining giant's could generate big returns over the next 12 months. The post 2 of the very best ASX ...
Super Micro may also face margin pressures as it focuses on share gains. Customer concentration risks and prior financial ...
This gold miner could be a top pick for investors wanting exposure to this side of the market. The post Goldman Sachs says ...
10don MSN
Goldman Sachs strategists listed their “rising stars.” These are Russell 1000 (NYSEARCA:IWB) stocks with the largest increase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results